Systems Analysis of the 22q11.2 Microdeletion Syndrome Converges on a Mitochondrial Interactome Necessary for Synapse Function and Behavior
- 4 March 2019
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 39 (18) , 3561-3581
Abstract
Neurodevelopmental disorders offer insight into synaptic mechanisms. To unbiasedly uncover these mechanisms, we studied the 22q11.2 syndrome, a recurrent copy number variant, which is the highest schizophrenia genetic risk factor. We quantified the proteomes of 22q11.2 mutant human fibroblasts from both sexes and mouse brains carrying a 22q11.2-like defect, Df(16)A+/−. Molecular ontologies defined mitochondrial compartments and pathways as some of top ranked categories. In particular, we identified perturbations in the SLC25A1-SLC25A4 mitochondrial transporter interactome as associated with the 22q11.2 genetic defect. Expression of SLC25A1-SLC25A4 interactome components was affected in neuronal cells from schizophrenia patients. Furthermore, hemideficiency of the Drosophila SLC25A1 or SLC25A4 orthologues, dSLC25A1-sea and dSLC25A4-sesB, affected synapse morphology, neurotransmission, plasticity, and sleep patterns. Our findings indicate that synapses are sensitive to partial loss of function of mitochondrial solute transporters. We propose that mitoproteomes regulate synapse development and function in normal and pathological conditions in a cell-specific manner. SIGNIFICANCE STATEMENT We address the central question of how to comprehensively define molecular mechanisms of the most prevalent and penetrant microdeletion associated with neurodevelopmental disorders, the 22q11.2 microdeletion syndrome. This complex mutation reduces gene dosage of ∼63 genes in humans. We describe a disruption of the mitoproteome in 22q11.2 patients and brains of a 22q11.2 mouse model. In particular, we identify a network of inner mitochondrial membrane transporters as a hub required for synapse function. Our findings suggest that mitochondrial composition and function modulate the risk of neurodevelopmental disorders, such as schizophrenia.Keywords
All Related Versions
This publication has 96 references indexed in Scilit:
- A Census of Human Soluble Protein ComplexesCell, 2012
- Sleep Fragmentation and Motor Restlessness in a Drosophila Model of Restless Legs SyndromeCurrent Biology, 2012
- CNVs: Harbingers of a Rare Variant Revolution in Psychiatric GeneticsCell, 2012
- 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophreniaNature Reviews Neuroscience, 2010
- MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1/2Cell Metabolism, 2009
- The co‐occurrence of early onset Parkinson disease and 22q11.2 deletion syndromeAmerican Journal of Medical Genetics Part A, 2009
- Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genesMolecular and Cellular Neuroscience, 2008
- A Mitochondrial Protein Compendium Elucidates Complex I Disease BiologyCell, 2008
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- The GTPase dMiro Is Required for Axonal Transport of Mitochondria to Drosophila SynapsesNeuron, 2005